首页> 外文期刊>Clinical and experimental hypertension: CEH >Which is a better treatment for hypertensive patients with diabetes: A combination of losartan and hydrochlorothiazide or a maximum dose of Losartan?
【24h】

Which is a better treatment for hypertensive patients with diabetes: A combination of losartan and hydrochlorothiazide or a maximum dose of Losartan?

机译:氯沙坦与氢氯噻嗪联用或最大剂量的氯沙坦对高血压的糖尿病患者哪种治疗更好?

获取原文
获取原文并翻译 | 示例
           

摘要

Background: This 12-month study compared the effects of a combination of losartan 50 mg and hydrochlorothiazide 12.5 mg with a maximum dose of losartan (100 mg) in hypertensive patients with diabetes. Methods: This was a multicenter randomized open-label study. Results: A similar reduction in systolic/diastolic blood pressure from baseline to month 3 was observed in both groups. There was also a similar decrease in UACR in both groups. A significant decrease in uric acid was observed in the maximum-dose group only. eGFR decreased in the combination group after 1 year. Conclusions: The combination of losartan and a diuretic may be a useful option in such hypertensive patients with diabetes, provided that metabolic parameters are closely monitored. In patients with hyperuricemia and impaired renal function, a maximum dose of losartan may be more beneficial.
机译:背景:这项为期12个月的研究比较了50毫克氯沙坦和12.5毫克氢氯噻嗪与最大剂量的氯沙坦(100毫克)联合治疗对高血压糖尿病患者的影响。方法:这是一项多中心随机开放标签研究。结果:两组均观察到从基线到第3个月收缩压/舒张压的相似降低。两组的UACR也有类似的下降。仅在最大剂量组中观察到尿酸显着降低。 1年后联合治疗组的eGFR下降。结论:如果密切监测代谢参数,氯沙坦和利尿剂的组合在此类高血压糖尿病患者中可能是有用的选择。在高尿酸血症和肾功能受损的患者中,最大剂量的氯沙坦可能更有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号